CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
Atlanta, Georgia, United States and 33 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Dunwoody, Georgia, United States and 124 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Atlanta, Georgia, United States and 263 other locations
This study was designed to evaluate safety and antitumor activity of HER3-DXd in two parts: Dose Escalation and Dose Expansion.In Dose Escalation, HE...
Phase 1
Atlanta, Georgia, United States and 36 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Gainesville, Georgia, United States and 95 other locations
The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\] by inves...
Phase 2
Atlanta, Georgia, United States and 80 other locations
Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sit...
Phase 3
Newnan, Georgia, United States and 71 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Marietta, Georgia, United States and 182 other locations
purpose of this study is to evaluate how well Rina-S works against lung cancer.The treatment in this study is Rina-S monotherapy (b...
Phase 2
Atlanta, Georgia, United States and 73 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...
Phase 3
Atlanta, Georgia, United States and 327 other locations
Clinical trials
Research sites
Resources
Legal